Hypoxia positively regulates the expression of pH-sensing G-protein-coupled receptor OGR1 (GPR68) by de Vallière, Cheryl et al.
Zurich Open Repository and
Archive
University of Zurich
Main Library
Strickhofstrasse 39
CH-8057 Zurich
www.zora.uzh.ch
Year: 2016
Hypoxia positively regulates the expression of pH-sensing G-protein-coupled
receptor OGR1 (GPR68)
de Vallière, Cheryl; Cosin-Roger, Jesus; Simmen, Simona; Atrott, Kirstin; Melhem, Hassan; Zeitz,
Jonas; Madanchi, Mehdi; Tcymbarevich, Irina; Fried, Michael; Kullak-Ublick, Gerd A; Vavricka,
Stephan R; Misselwitz, Benjamin; Seuwen, Klaus; Wagner, Carsten A; Eloranta, Jyrki J; Rogler,
Gerhard; Ruiz, Pedro A
Abstract: BACKGROUND AIMS A novel family of proton-sensing G-protein-coupled receptors, includ-
ing ovarian cancer G-protein-coupled receptor 1 (OGR1) (GPR68) has been identified to play a role in pH
homeostasis. Hypoxia is known to change tissue pH as a result of anaerobic glucose metabolism through
the stabilization of hypoxia-inducible factor-1￿. We investigated how hypoxia regulates the expression of
OGR1 in the intestinal mucosa and associated cells. METHODS OGR1 expression in murine tumors,
human colonic tissue, and myeloid cells was determined by quantitative reverse-transcription polymerase
chain reaction. The influence of hypoxia on OGR1 expression was studied in monocytes/macrophages and
intestinal mucosa of inflammatory bowel disease (IBD) patients. Changes in OGR1 expression in Mono-
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volved, chromatin immunoprecipitation analysis of the OGR1 promoter was performed. RESULTS OGR1
expression was significantly higher in tumor tissue compared with normal murine colon tissue. Hypoxia
positively regulated the expression of OGR1 in MM6 cells, mouse peritoneal macrophages, primary hu-
man intestinal macrophages, and colonic tissue from IBD patients. In MM6 cells, hypoxia-enhanced
TNF-induced OGR1 expression was reversed by inhibition of NF-￿B. In addition to the effect of TNF and
hypoxia, OGR1 expression was increased further at low pH. Chromatin immunoprecipitation analysis
showed that HIF-1￿, but not NF-￿B, binds to the promoter of OGR1 under hypoxia. CONCLUSIONS
The enhancement of TNF- and hypoxia-induced OGR1 expression under low pH points to a positive
feed-forward regulation of OGR1 activity in acidic conditions, and supports a role for OGR1 in the
pathogenesis of IBD.
DOI: https://doi.org/10.1016/j.jcmgh.2016.06.003
Posted at the Zurich Open Repository and Archive, University of Zurich
ZORA URL: https://doi.org/10.5167/uzh-134951
Veröffentlichte Version
 
 
Originally published at:
de Vallière, Cheryl; Cosin-Roger, Jesus; Simmen, Simona; Atrott, Kirstin; Melhem, Hassan; Zeitz, Jonas;
Madanchi, Mehdi; Tcymbarevich, Irina; Fried, Michael; Kullak-Ublick, Gerd A; Vavricka, Stephan R;
Misselwitz, Benjamin; Seuwen, Klaus; Wagner, Carsten A; Eloranta, Jyrki J; Rogler, Gerhard; Ruiz,
Pedro A (2016). Hypoxia positively regulates the expression of pH-sensing G-protein-coupled receptor
OGR1 (GPR68). Cellular and Molecular Gastroenterology and Hepatology, 2(6):796-810.
DOI: https://doi.org/10.1016/j.jcmgh.2016.06.003
2
ORIGINAL RESEARCH
Hypoxia Positively Regulates the Expression of pH-Sensing
G-Protein–Coupled Receptor OGR1 (GPR68)
Cheryl de Vallière,1,* Jesus Cosin-Roger,1,2,* Simona Simmen,1 Kirstin Atrott,1
Hassan Melhem,1 Jonas Zeitz,1 Mehdi Madanchi,1 Irina Tcymbarevich,1 Michael Fried,1
Gerd A. Kullak-Ublick,3 Stephan R. Vavricka,1 Benjamin Misselwitz,1 Klaus Seuwen,4
Carsten A. Wagner,5 Jyrki J. Eloranta,3 Gerhard Rogler,1 and Pedro A. Ruiz1
1Division of Gastroenterology and Hepatology, 3Department of Clinical Pharmacology and Toxicology, 5Institute of Physiology,
University Hospital Zurich, Zurich, Switzerland; 2Department of Pharmacology and Biomedical Research Networking Center in
Hepatic and Digestive Diseases (CIBERehd), Faculty of Medicine, University of Valencia, Valencia, Spain; 4Novartis Institutes for
Biomedical Research, Basel, Switzerland
SUMMARY
Hypoxia induces the expression of pH-sensing ovarian can-
cer G-protein–coupled receptor 1 (GPR68) in monocytes/
macrophages and intestinal mucosa of inﬂammatory bowel
disease patients, which is enhanced further at acidic pH in
monocytes/macrophages. Hypoxia-inducible factor-1a binds
to the ovarian cancer G-protein–coupled receptor 1 pro-
moter under hypoxia, pointing to the direct regulation of
this gene.
BACKGROUND & AIMS: A novel family of proton-sensing
G-protein–coupled receptors, including ovarian cancer
G-protein–coupled receptor 1 (OGR1) (GPR68) has been iden-
tiﬁed to play a role in pH homeostasis. Hypoxia is known to
change tissue pH as a result of anaerobic glucose metabolism
through the stabilization of hypoxia-inducible factor-1a. We
investigated how hypoxia regulates the expression of OGR1 in
the intestinal mucosa and associated cells.
METHODS: OGR1 expression in murine tumors, human
colonic tissue, and myeloid cells was determined by quanti-
tative reverse-transcription polymerase chain reaction. The
inﬂuence of hypoxia on OGR1 expression was studied in
monocytes/macrophages and intestinal mucosa of inﬂamma-
tory bowel disease (IBD) patients. Changes in OGR1 expres-
sion in MonoMac6 (MM6) cells under hypoxia were
determined upon stimulation with tumor necrosis factor
(TNF), in the presence or absence of nuclear factor-kB (NF-kB)
inhibitors. To study the molecular mechanisms involved,
chromatin immunoprecipitation analysis of the OGR1
promoter was performed.
RESULTS: OGR1 expression was signiﬁcantly higher in tumor
tissue compared with normal murine colon tissue. Hypoxia
positively regulated the expression of OGR1 in MM6 cells,
mouse peritoneal macrophages, primary human intestinal
macrophages, and colonic tissue from IBD patients. In MM6
cells, hypoxia-enhanced TNF-induced OGR1 expression was
reversed by inhibition of NF-kB. In addition to the effect of TNF
and hypoxia, OGR1 expression was increased further at low pH.
Chromatin immunoprecipitation analysis showed that HIF-1a,
but not NF-kB, binds to the promoter of OGR1 under hypoxia.
CONCLUSIONS: The enhancement of TNF- and hypoxia-induced
OGR1 expression under low pH points to a positive feed-
forward regulation of OGR1 activity in acidic conditions, and
supports a role for OGR1 in the pathogenesis of IBD. (Cell Mol
Gastroenterol Hepatol 2016;2:796–810; http://dx.doi.org/
10.1016/j.jcmgh.2016.06.003)
Keywords: Ovarian Cancer G-Protein–Coupled Receptor;
Inﬂammation; Inﬂammatory Bowel Disease; TDAG8; GRP65.
Cells in diseased tissues, such as malignant tumors,atherosclerotic plaques, arthritic joints, and chroni-
cally inﬂamed tissue, experience prolonged periods of
hypoxia. A family of hypoxia-inducible factor (HIF) tran-
scription factors is predominately responsible for mediating
cellular adaptation to low oxygen availability.1,2 HIF-1a has
been implicated in a number of inﬂammatory diseases
including rheumatoid arthritis, allergic asthma, psoriasis,
and inﬂammatory bowel disease (IBD).3
Hypoxia and inﬂammation are interconnected and linked
on many levels and may induce and inﬂuence each other in
various ways.4 Inﬂammation may be hypoxia-driven or
hypoxia may be induced by inﬂammation (inﬂammatory
hypoxia).4 Hypoxia not only maintains or aggravates
inﬂammation via stabilization of HIF-1a, but it also
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inﬂuences the local tissue pH in the mucosa.5 Subsequently,
an acidic environment is not only the result of an inﬂam-
mation, but also affects the degree and outcome of inﬂam-
mation.6–8 Inﬂammation has been attributed to an increase
in local proton concentration and lactate production,9–11
and linked to subsequent proinﬂammatory cytokine pro-
duction, such as tumor necrosis factor (TNF), interleukin
(IL)6, interferon-g, and IL1b.
Hypoxia is also a consequence of solid tumor formation.
Larger colorectal cancers with insufﬁcient angiogenesis are
characterized by a lack of oxygen supply. However, even in the
case of sufﬁcient oxygen supply, as ﬁrst described byWarburg
et al12 in 1924, cancer cells preferentially may metabolize
glucose to lactate by an anaerobic pathway (known as the
Warburg effect). Lactate induces the expression of HIF-1a and
causes acidiﬁcation of the surrounding tissue.13-15
Hypoxia inﬂicts a broad spectrum of effects on the
cellular, organ, and systemic levels. In the intestine, hypoxic
conditions affect different processes including absorption,
metabolism, and inﬂammation.16,17 During mucosal inﬂam-
mation, edema, vasculitis, and vasoconstriction separate
epithelial and other cells from the blood supply and thus
access to oxygen. Karhausen et al18 showed that even at
basal conditions some extent of hypoxia is detectable in the
superﬁcial epithelial layers of the murine colon. After
induction of colitis in a mouse model, aggravated hypoxia
occurred, and even reached submucosal regions.18
HIF-1a is an oxygen-sensing transcription factor that
regulates the expression of various genes enhancing oxygen
delivery or promotes cell survival under hypoxic conditions.
Heterodimeric transcription factor HIF-1a undergoes
oxygen-dependent hydroxylation, which leads to binding of
the von Hippel-Lindau tumor suppressor protein and sub-
sequent ubiquitin-mediated proteosomal degradation. No
hydroxylation occurs under hypoxic conditions, followed by
an accumulation of HIF-1a and binding to HIF-1b, forming
the active HIF-1 complex. The active HIF-1 dimer binds to
hypoxia response elements in the DNA, thereby leading to
the expression or suppression of its target genes.19
A family of G-protein–coupled receptors, which includes
ovarian cancer G-protein–coupled receptor 1 (OGR1, also
known as G-protein–coupled receptor [GPR]68), GPR4, and
T-cell death-associated gene 8 (TDAG8, also known as
GPR65), sense extracellular protons through imidazole
groups on histidine residues located on the extracellular
region of the receptor.20,21 Signaling pathways induced by
protons binding to the receptor include phospholipase C
activation, inositol trisphosphate formation, and subsequent
Ca2þ release via the Gq pathway
20,22,23 or cyclic adenosine
monophosphate production through the Gs pathway.
24,25
Recent studies have shown a link between IBD and this
family of pH-sensing G-protein–coupled receptors. TDAG8
has been identiﬁed as an IBD risk gene by association re-
sults and meta-analysis of genome-wide association
studies.26,27 Furthermore, single-cell RNA sequencing and
computational analysis, which is used to determine different
cellular states of T-helper (Th)17 cells and rank genes based
on their pathogenicity, recently has shown that TDAG8
promotes Th17 cell pathogenicity.28 In addition, chromatin
immunoprecipitation (ChIP) sequencing analysis shows that
the Th17 cell master transcription factor (Rorgt) binds the
promoter region of GPR65.29
In a previous study we reported that IBD patients
expressed higher levels of OGR1 messenger RNA (mRNA) in
the mucosa than healthy control subjects.22 We also
observed that OGR1 expression is induced in cells of human
macrophage lineage and primary human monocytes by TNF,
whereby this effect is reversed by inhibition of the key
regulator of chronic mucosal inﬂammation, nuclear tran-
scription factor-kB (NF-kB). These studies proposed a role
for OGR1 in the development of mucosal inﬂammation,
showing that accumulation of extracellular protons pro-
motes predominately Gq signaling in monocytes/macro-
phages and intestinal epithelial cells (IECs), causing
modulation of cellular responses, such as F-actin stress ﬁber
formation and tightening of the epithelial barrier.22,23
Hypoxia induces a decrease in tissue pH that may be
sensed by OGR1, thereby inﬂuencing inﬂammation, howev-
er, information on its signaling remains limited. Therefore,
we investigated the role of OGR1 during hypoxia associated
with inﬂammation. We studied the expression of OGR1 in a
human monocyte model, in primary intestinal macrophages
and in IBD patients subjected to hypoxia. We show that
OGR1 expression is enhanced by hypoxia. In a human cell
model subjected to hypoxia, TNF-induced OGR1 expression
was abrogated by NF-kB inhibition.
Materials and Methods
Chemicals
All chemicals and cytokines were obtained from Sigma-
Aldrich (St. Louis, MO), unless otherwise stated. All cell cul-
ture reagents were obtained from Thermo Fisher (Allschwil,
Switzerland), unless otherwise speciﬁed. TNF (#654205) was
purchased from Calbiochem (Merck, Darmstadt, Germany).
5-aminoimidazole-4-carboxamide-1-b-4-ribofuranoside (AICAR)
(#100102-41), BAY-11-7082 (#100010266), CAY10512
(#10009536), curcumin (#81025.1), SC-514 (#10010267),
and SP600125 (#100010466) were purchased from
Cayman (Ann Arbor, MI). The custommonoclonal anti-OGR1
antibody was developed by AbMart (Shanghai, China).
Human Subjects and Exposure
to Hypobaric Hypoxia
Human colon biopsy specimens were taken from patients
with Crohn’s disease (CD) or ulcerative colitis (UC), or from
healthy volunteers (HVs). HVs (n¼ 10), CD patients (n¼ 11),
and UCpatients (n¼ 9) in clinical remissionwere subjected to
hypoxic conditions in a hypobaric chamber resembling an
altitude of 4000m above sea level for 3 hours. Clinical activity
in patients with CD and in patients with UC was assessed
using the Harvey–Bradshaw Index and the Partial Mayo Score,
respectively. The participant characteristics are shown in
Table 1. Distal colon biopsy specimens were collected the day
before entering the hypobaric chamber (T1), immediately
after hypoxia (T2), and 1week after theﬁrst biopsy (T3) at the
Division of Gastroenterology andHepatology of the University
Hospital Zurich. Total RNA was isolated, reverse-transcribed,
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and hypoxia-induced changes in gene expression were
analyzed using quantitative reverse-transcription polymerase
chain reaction (RT-qPCR). This study was approved by
the Ethics Committee of the Canton of Zurich (KEK-ZH no.
2013-0284) and all participants signed an informed consent.
Human Intestinal Macrophage Isolation
Surgical specimens from human intestinal mucosa were
obtained from healthy intestinal resections from carcinoma
patients undergoing large- or small-bowel surgery. Written
consent was obtained before specimen collection, and
studies were approved by the local ethics committee. Human
intestinal macrophages were isolated from surgical speci-
mens as previously described.30 Brieﬂy, the tissue was
incubated in Hank’s balanced salt solution with dithiothreitol
(10 mmol/L) for 30 minutes, followed by EDTA (1 mmol/L)
treatment for 10 minutes at 37C to remove intestinal
epithelial cells. The tissue was digested in 2 mL phosphate-
buffered saline with 1 mg/mL collagenase type I (336 U/
mL; Sigma-Aldrich, Munich, Germany), 0.3 mg/mL DNase
(Roche, Basel, Switzerland), and 0.2 mg/mL hyaluronidase (2
mg/mL; Sigma-Aldrich) without fetal calf serum (FCS) for 60
minutes at 37C. After centrifugation through Ficoll–Paque
(Sigma-Aldrich), the cells collected from the interface frac-
tion were labeled with CD33 microbeads (Miltenyi Biotec,
Bergisch Gladbach, Germany) and sorted by magnetic sepa-
ration according to the manufacturer’s instructions (Auto-
MACS; Miltenyi Biotec). Cell purity was assessed by ﬂow
cytometry (>95% purity was obtained).
Cell Culture and Hypoxia Treatment
The human monocytic cell line MonoMac 6 (MM6; ob-
tained from DSMZ [Leibniz, Germany]) was cultured in
RPMI (Sigma-Aldrich, Munich, Germany) supplemented with
10% FCS, 1% nonessential amino acids, and 1% oxalacetic
acid–pyruvate–insulin medium supplement (Sigma-Aldrich),
and maintained according to American Type Culture
Collection recommendations. The human monocytic cell line
THP1 was maintained in RPMI medium (Invitrogen, Carls-
bad, CA) supplemented with 10% FCS (VWR, Dietlikon,
Switzerland). The human colorectal adenocarcinoma cell
line showing IEC morphology, HT29, was obtained from the
German Collection of Cells and Microorganisms (DSMZ) and
cultured under conditions as recommended by the DSMZ.
Cells were exposed to hypoxia (0.2% or 2% O2) in a
hypoxia workstation incubator (In vivo 400; Ruskin Tech-
nology, Leeds, UK); the addition of cytokines or inhibitors
was performed in the hypoxic chamber. Cells that were
maintained in normoxia (21% O2) for the same time period
of treatment were used as controls.
pH experiments
The pH shift experiments were performed in serum-free
RPMI medium with 2 mmol/L cell culture reagent and
20mmol/L HEPES. The pH of all solutionswas adjusted using
a calibrated pH meter (Metrohm, Herisau, Switzerland), the
appropriate quantities of NaOH or HCl were added and the
medium was allowed to equilibrate in the 5% CO2 incubator
for at least 36 hours. All data presented in this article are
referenced to pH measured at room temperature.
Animal Models
All animal experiments were performed according to
Swiss animal welfare laws and were approved by the Vet-
erinary Ofﬁce of the Canton Zurich (Switzerland).
Murine tumor model. C57BL/6/129 mice (age, 6–8 wk)
were injected intraperitoneally with a single dose (7.4 mg/
kg) of the mutagenic agent azoxymethane followed by 3
cycles of 3% dextran sodium sulfate in drinking water for 1
week and regular drinkingwater for 2weeks ad libitum. Mice
were killed 10 days after the last cycle for sample collection.
OGR1-deﬁcient mouse model. Ogr1-/- (C57BL/6) mice
were generated by and obtained from Deltagen, Inc (San
Mateo, CA), as previously described.31
Genomic DNA Extraction and Genotyping
For PCR reactions, the oligonucleotides used were
as follows: Ogr1 genotyping: 5’-ACCACCAGTGATGCCTA-
GATCCTGA-3’ (P416), 5’-AAGATGACCACGGTGCTGAGCACCA-
3’ (P417), and 5’-CCATTCGACCACCAAGCGAAACATC-3’ (R3).
Table 1.Participant Characteristics
Item HVs CD UC
Number of patients 10 11 9
Sex: females, n 3 (30%) 6 (54.5%) 5 (55.6%)
Age, mean ± SD, y 28.2 ± 4.9 35.2 ± 13.3 31.8 ± 10.8
Smoking status 2/10 (20.0%) 3/11 (27.3%) 2/9 (22.2%)
Disease severity
Harvey–Bradshaw Index, median (IQR) NA 0.0 NA
Partial Mayo score, median (IQR) NA NA 0.0
Medical history
Azathioprine/6-MP NA 5/11 (45.5%) 7/9 (58.3%)
Methotrexate NA 1/11 (9.1%) 0/9 (0.0%)
Anti-TNF NA 6/11 (54.5%) 2/9 (16.7%)
Systemic steroids NA 1/11 (9.1%) 3/9 (25.0%)
NSAID intake NA 2/11 (18.2%) 6/9 (75.0%)
IQR, interquartile range; MP, mercaptopurine; NA, not applicable; NSAID, nonsteroidal anti-inﬂammatory drug.
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Murine Macrophage Isolation and Culture
Mature quiescent macrophages from age-matched male
Ogr1-/- and wild-type (WT) mice (C57BL/6) were isolated
from the mouse peritoneal cavity, as previously described.22
Animals were killed by cervical dislocation to reduce inﬂu-
ence of pH. Peritoneal murine macrophages were centri-
fuged, washed in phosphate-buffered saline, and
resuspended in RPMI 1640 medium containing 2 mmol/L
Glutamax, 10% FCS, 100 U/mL penicillin, and 100 mg/mL
streptomycin. After 2 hours, nonadherent cells were
removed and the macrophages were cultured under nor-
moxia or hypoxia at various pH conditions for 24 hours.
RNA Extraction and RT-qPCR
Tissue used for RNA analysis was transferred immedi-
ately into RNAlater solution (Qiagen, Valencia, CA) and
stored at -80C. Tissue biopsy specimens were disrupted in
RLT buffer (Qiagen) using a 26G needle. Total RNA was
isolated using the RNeasy Mini Kit in the automated
QIAcube following the manufacturer’s recommendations
(Qiagen, Hombrechtikon, Switzerland). For removal of re-
sidual DNA, DNase treatment, 15 minutes at room temper-
ature, was integrated into the QIAcube program according
to the manufacturer’s instructions. For complementary DNA
synthesis, the High-Capacity Complementary DNA Reverse
Transcription Kit (Applied Biosystems, Foster City, CA), was
used, following the manufacturer’s instructions. Determi-
nation of mRNA expression was performed by RT-qPCR on a
7900HT real-time PCR system (Applied Biosystems), under
the following cycling conditions: 20 seconds at 95C, then
45 cycles of 95C for 3 seconds, and 60C for 30 seconds
with the TaqMan Fast Universal Mastermix (Thermo Fisher
Scientiﬁc, Wohlen, Switzerland). Samples were analyzed as
triplicates. Relative mRNA expression was determined by
the comparative DDCt method,32 which calculates the
quantity of the target sequences relative to the endogenous
control and a reference sample. TaqMan Gene Expression
Assays (all from Applied Biosystems) used in this study
were mouse Mm00558545_s1 GPR68 (OGR1),
Mm00433695_m1 GPR65 (TDAG8), Mm00446190_m1 IL6,
Mm00486332_m1 secreted protein, acidic, cysteine-rich
(SPARC), Mm99999068_m1 TNF, mouse b-actin (ACTB)
VIC TAMRA (4352341E), human Hs 00268858_s1 GPR68
(OGR1), Hs 00269247_s1 GPR65 (TDAG8), Hs 00270999_s1
GPR4, Hs00174131_m1 IL6, Hs00174103_m1 IL8,
Hs00234160_m1 human SPARC, Hs00174128_m1 TNF, and
human b-actin Vic TAMRA (4310881E).
Immunoblotting
Total protein was extracted from colon biopsy speci-
mens by lysing homogenized tissue in a RIPA buffer (0.5%
sodium deoxycholate, 0.1% sodium dodecyl sulfate, 1% NP-
40) supplemented with protease inhibitors (Roche Di-
agnostics, Mannheim, Germany). For each group, a total of
25 mg protein was transferred to a nitrocellulose membrane
after electrophoretic separation. The membrane then was
incubated overnight with OGR1 primary antibody (AbMart).
After washing in Tris-buffered saline, the anti-mouse
secondary antibody conjugated to horseradish peroxidase
was added, and the membrane was incubated at room
temperature for 1 hour. After washing in Tris-buffered
saline, the proteins were visualized using the ECL Plus
detection kit (Amersham, Velizy-Villacoublay, France).
b-actin was used as an internal reference control.
Chromatin Immunoprecipitation Analysis
After the treatment of THP1 cells, ChIP analysis was
performed using the ChIP-IT Express Enzymatic kit (Active
Motif, La Hulpe, Belgium) according to the manufacturer’s
instructions. Brieﬂy, after ﬁxation and lysis of the cells, the
chromatin was sheared using the enzymatic shearing cock-
tail. Immunoprecipitation of 25 mg chromatin was performed
overnight at 4C using 3 mg of anti–HIF-1a (BD Biosciences,
San Jose, CA) or 3 mg of anti–NF-kB (Cell Signaling, ZA Lei-
den, The Netherlands) antibodies. After washing the mag-
netic beads, DNA cross-links of the immune complexes were
reverted by heating for 15 minutes at 95C followed by
proteinase K digestion for 1 hour at 37C. DNA isolated from
an aliquot of the total nuclear extract was used as a loading
control for the PCR (input control). PCR was performed
with total DNA and immunoprecipitated DNA using the
following promoter-speciﬁc primers: for -1680 HIF-1
binding site: 5’-TTGCGTGGCTACTGATTTGC-3’ (forward)
and 5’-GAACAGTCCAGGAGTAGCCC-3’ (reverse), for -1225
NF-kB binding site: 5’-GGGGAAATGCAGTGAATGAGC-3’
(forward) and 5’-CAGTGCCAGTGATGTTTGCAT-3’ (reverse),
for -959 NF-kB binding site: 5’- GATTTGAACCTAGG-
CAGTGGG-3’ (forward) and 5’- TTTCCAGCCTTAACTGCCTG-3’
(reverse), and for -688 HIF-1a and -221 NF-kB binding
sites: 5’-GAGCTGCAACACCGCACTTC-3’ (forward), 5’-GAACG-
CAGGGCCAAGTTGTG-3’ (reverse). The PCR products (10 mL)
were subjected to electrophoresis on a 2% agarose gel.
Data Analysis and Statistics
Data are presented as means ± SEM for a series of n
experiments. Statistical analysis of mouse data was per-
formed using a paired Student t test, and probabilities
(P value, 2 tailed) with a P value less than .05 were
considered statistically signiﬁcant. For statistical analysis of
groups, 1-way analysis of variance was performed followed
by the Tukey post hoc test. Differences were considered
signiﬁcant at a P value of less than .05, highly signiﬁcant at a
P value of < .01, and very highly signiﬁcant at a P value of
less than .001.
All authors had access to the study data and reviewed
and approved the ﬁnal manuscript.
Results
OGR1 Expression in Murine Tumor Tissue Is
Increased Compared With Normal Tissue
We examined OGR1 mRNA expression levels in a murine
colorectal cancer model. OGR1 expression was signiﬁcantly
higher (2.8-fold; P < .05) in tumor tissue compared with
normal colon tissue. Groups were as follows: control, n ¼ 7;
tumor group: n ¼ 7 (Figure 1A).
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IBD Patients Under Hypoxia Show an Enhanced
OGR1 mRNA Expression When Compared With
Healthy Controls
To study the effects of hypoxia on the expression of
the pH-sensing receptors OGR1 and TDAG8 in the colon
of human subjects, HVs (n ¼ 10), CD patients (n ¼ 11),
and UC patients (n ¼ 9) were subjected to hypoxic con-
ditions in a hypobaric chamber resembling an altitude of
4000 m above sea level for 3 hours. Although not sig-
niﬁcant, the mRNA expression of OGR1 showed a clear
trend to an increase 1 week after hypoxia in CD and UC
patients when compared with HVs (Figure 1B). In addi-
tion, Western blot analysis of OGR1 showed that the
expression of OGR1 was increased in the colon of CD and
UC patients after exposure to hypoxia as compared with
the control group (Figure 1D). Conversely, mRNA levels
of TDAG8 in CD patients, but not HVs, were reduced
signiﬁcantly at T2 and T3 after hypoxia when compared
with T1, and a similar trend was shown in UC patients
(Figure 1C).
Figure 1. OGR1 expression increases in tumor and under hypoxia. (A) OGR1 expression increases in murine tumors. To
induce colon carcinomas, mice were injected intraperitoneally with a single dose of azoxymethane (7.4 mg/kg), followed by 3
cycles of 3% dextran sodium sulfate in drinking water for 1 week and normal drinking water for 2 weeks. Mice were killed 10
days after the last cycle for colonic tumor collection. OGR1 mRNA expression levels were signiﬁcantly higher (P ¼ .0220) in
murine colonic tumors compared with the normal colonic mucosa. Groups: control (n ¼ 7), tumor group (n ¼ 7). (B and C)
Hypoxia induces a tendency to increase OGR1 mRNA expression and signiﬁcantly decreases TDAG8 mRNA expression in the
colon of IBD patients. HVs (n ¼ 10), CD patients (n ¼ 11), and UC patients (n ¼ 9) were subjected to hypoxic conditions in a
hypobaric chamber resembling an altitude of 4000 m for 3 hours. Distal colon biopsy specimens were taken the day before
entering the hypobaric chamber (T1), immediately after hypoxia (T2), and 1 week after the ﬁrst biopsy (T3). Total RNA was
isolated, reverse-transcribed, and hypoxia-induced changes in gene expression were analyzed using RT-qPCR. (B) Although
not signiﬁcant, OGR1 mRNA expression after hypoxia showed an increasing tendency at T3 in CD and UC patients when
compared with HVs. (C) Conversely, mRNA levels of TDAG8 were reduced signiﬁcantly at T1 and T3 in CD patients subjected
to hypoxia. Expression changes were calculated relative to samples taken at T1 after normalizing with human b-actin
endogenous control. (D) Immunoblotting analysis of OGR1 in colon biopsy specimens from HVs, CD patients, and UC patients
as described earlier. b-actin was used as loading control. Results represent means ± SEM. Statistical analysis was performed
using 1-way analysis of variance followed by the Tukey test (*P < .05, **P < .01, ***P < .001).
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Hypoxia Induces OGR1 Expression in Cultured
Human IECs and Monocytes
Because our results suggest a positive regulation of OGR1
expression in IBD patients under hypoxia, we sought to
conﬁrm this effect in IECs and monocytic cells because these
cell types cells play a major role in gut innate immunity and
homeostasis. For this purpose, we subjected cultured human
monocytic THP1 cells to hypoxia (0.2% O2) for 8, 16, and 24
hours, and the IEC line HT29 for 24 hours. Hypoxia signi-
ﬁcantly induced OGR1 mRNA expression in THP1 cells
Figure 2. Hypoxia induces the mRNA expression of OGR1 in cultured human IECs and monocytes. (A and B) HT29 and
THP1 cells were incubated under hypoxic conditions (0.2% O2) for 8, 16, and 24 hours. Total RNA was isolated, reverse-
transcribed, and hypoxia-induced changes in gene expression were analyzed using RT-qPCR. Hypoxia signiﬁcantly
induced the mRNA expression of OGR1. Results represent means ± SEM of 2 independent experiments. Statistical analysis
was performed using the Student t test (n ¼ 5; *P < .05, **P < .01, ***P < .001).
Figure 3. Expression of
pH-sensing receptors
OGR1 and TDAG8
changed under hypoxic
conditions. MonoMac 6
cells were exposed to quite
severe hypoxia (0.2% O2)
or modest hypoxia (2% O2)
for 18 hours. (A) OGR1
expression increased 2-
fold and 1.7-fold at 0.2%
and 2% O2, respectively.
(B) Conversely, TDAG8
mRNA expression de-
creased 0.7- and 0.6-fold
at 0.2% and 2% O2,
respectively. (C) OGR1
mRNA expression re-
mained unchanged from
0 to 8 hours, but increased
1.6- and 2.3-fold after 16
and 24 hours, respectively.
Each ﬁgure is representa-
tive of at least 3 indepen-
dent experiments. Results
are expressed as means ±
SD. *P < .05, **P < .01,
and ***P < .001 using
1-way analysis of variance
followed by the Tukey test.
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(4.76-, 13.19-, and 3.82-fold increase; P ¼ .0067, P ¼ .0005,
P ¼ .02) at 8, 16, and 24 hours, respectively (Figure 2A), and
HT29 cells (7.78-fold increase; P ¼ .0042) (Figure 2B).
We next investigated the effects of hypoxia on the
expression of the pH-sensing receptors in the human cell
line MM6, which shows characteristics and functional
features of mature blood monocytes.33,34 Expression
levels of the pH-sensing receptors OGR1, GPR4, and
TDAG8, in MM6 cells exposed to severe hypoxia (0.2% O2)
or modest hypoxia (2% O2) for 18 hours, were examined
by RT-qPCR. OGR1 mRNA expression increased (2- and
1.7-fold; P < .05 and P < .01) at 0.2% and 2% O2,
respectively (Figure 3A). Conversely, TDAG8 expression
decreased (0.7- and 0.6-fold; P < .001 and P < .001) at
0.2% and 2% O2, respectively (Figure 3B). The expression
of GPR4 in MM6 cells was very low and hypoxia did not
signiﬁcantly affect GPR4 gene expression (data not
shown). Because GPR4 is only weakly expressed in
myeloid cells and IECs, further experiments in this study
focused only on OGR1 and TDAG8.
To determine the induction time required to induce
OGR1 expression in MM6 cells under hypoxia (0.2% O2), we
selected 5 different time points (0–24 h); no change was
detected at 8 hours, but at time points of 16 and 24 hours
expression increased 1.6- and 2.3-fold, respectively
(P < .001 and P < .001) (Figure 3C).
Figure 4. Expression of pH-sensing receptors OGR1 and TDAG8 under hypoxic conditions was inﬂuenced further by pH
in MM6 cells.MonoMac 6 cells were exposed to hypoxia (0.2% O2) for 24 hours at pH 7.7, pH 7.3, and pH 6.8. Under hypoxic
conditions: (A) OGR1 mRNA expression increased at acidic pH compared with expression at pH 7.7 or pH 7.3, (B) TDAG8
mRNA expression decreased in all conditions under hypoxia (ns), and (C) SPARC mRNA expression was increased signiﬁ-
cantly under hypoxia at pH 6.8. Results represent means ± SEM of 5 independent experiments. Asterisks denote signiﬁcant
differences from the respective control: *P < .05, and ***P < .001.
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Acidic pH Induces OGR1 and OGR1-Dependent
mRNA Expression in MM6 Cells Subjected
to Hypoxia
To assess the inﬂuence of pH in MM6 cells under hypoxia,
we compared expression levels of OGR1 and OGR1-
dependent genes at pH 7.7, 7.3, and 6.8 at hypoxic condi-
tions (0.2%O2 for 24 h) to normoxia, pH 7.7. Hypoxia induced
a higher expression of OGR1 in all pH levels analyzed, with the
highest increase at the acidic pH. OGR1 expression levels of
MM6 cells under hypoxia increased 3.2-, 3.7-, and 53.5-fold (P
< .001, P < .001, and P < .001) at pH 7.7, 7.3, and 6.8,
respectively, compared with pH 7.7, normoxia (Figure 4A).
Under hypoxia, OGR1 expression at acidic pH increased more
than 14-fold compared with pH 7.7 and pH 7.3. Conversely,
MM6 cells exposed to hypoxia at pH 7.7, 7.3, and 6.8 showed a
trend toward a decreased TDAG8 expression compared with
the respective normoxic conditions (Figure 4B).
In an earlier study, we observed that OGR1-induced gene
expression in response to extracellular acidiﬁcation in murine
macrophages was enriched for inﬂammation and immune
response, actin cytoskeleton, and cell-adhesion gene path-
ways.22 Therefore, in this study we examined the effect of
hypoxia on the expression levels of the highly regulated OGR1-
dependent gene SPARC, an extracellular matrix–associated
protein known to regulate the expression of matrix metal-
loproteinase and cytoskeleton architecture.35,36 An acidic
pH of 6.8 resulted in a 3.2-fold (P < .001) induction of
SPARC expression at normoxia and 7.3-fold (P < .001) at
hypoxia compared with pH 7.7 normoxia (Figure 4C).
Acidic pH Induces the Expression of pH
Receptors and Proinﬂammatory Cytokines
in Murine Peritoneal and Human Intestinal
Macrophages Under Hypoxia
To conﬁrm the effect of hypoxia and acidic pH on the
expression of pH receptors and proinﬂammatory cytokines
in primary macrophages, we isolated peritoneal macro-
phages from Ogr1-/- and WT mice and intestinal macro-
phages from healthy intestinal tissue from colon carcinoma
patients. The expression of OGR1, but not TDAG8, was
increased signiﬁcantly under hypoxia at pH 7.7, 7.3, and 6.8,
with a higher increase of OGR1 expression at acidic condi-
tions (Figures 5 and 6A and B). This result suggests that the
expression of OGR1 and TDAG8 under hypoxia is regulated
differentially at acidic conditions. Interestingly, hypoxia also
induced the expression of the proinﬂammatory cytokines
IL6, IL8, and TNF, but not SPARC, with a signiﬁcantly higher
expression at acidic conditions (Figures 5 and 6C and F).
Importantly, proinﬂammatory gene expression was reduced
signiﬁcantly in macrophages from OGR1-/- mice compared
with WT mice, conﬁrming a crucial role for OGR1 in
hypoxia-mediated changes in these genes.
TNF-Induced OGR1 Expression Is Enhanced
Under Hypoxia and Reversed in the Presence
of NF-kB Inhibitors
In a previous study we observed that treatment of
MM6 cells with TNF led to a signiﬁcant up-regulation of
OGR1 expression through a NF-kB–mediated mechanism,
with the maximum OGR1 expression occurring between 6
and 8 hours.22 This prompted us to examine the addi-
tional inﬂuence of hypoxia on TNF-treated MM6 cells in
the presence or absence of NF-kB inhibitors. Our results
show that control/nontreated cells exposed to hypoxia
for 6 and 24 hours increased 1.13- and 9.8-fold (P ¼ not
signiﬁcant and P < .001), respectively (Figure 7A and B).
Furthermore, OGR1 expression levels in MM6 cells
treated with TNF (25 ng/mL) and exposed to hypoxia
(0.2% O2) for 6 and 24 hours, increased 1.5- and
17.8-fold (P < .0001, .001) respectively, compared with
the corresponding treatment at normoxic conditions
(Figure 7A and B). Interestingly, hypoxic conditions and
TNF stimulation showed a synergistic effect in the in-
duction of OGR1 expression at 24 hours (Figure 7B).
Cells treated with TNF in the presence of the NF-kB
inhibitor SC-514 (25 mmol/L), which is known to inhibit the
kinase activity of inhibitor of kappa B kinase,37 showed
decreased OGR1 expression at normoxia (3.9-fold or 68%
decrease; P < .001) and hypoxia (5.74-fold or 80%
decrease; P < .001), relative to the corresponding controls.
The degree of inhibition between normoxic and hypoxic
conditions showed no signiﬁcant difference. However, the
inhibitory effect of SC-514 was less effective on longer
exposure to hypoxia (24 h) and we observed a 9.5-fold or
42% decrease (P < .001) in OGR1 expression compared
with normoxia (3.26-fold or 78% decrease; P < .001)
(Figure 7B).
In addition to SC-514, we also tested AICAR ribonucle-
oside, which blocks the expression of proinﬂammatory cy-
tokines (TNF, IL1b, and IL6), inducible nitric oxide synthase,
prostaglandin-endoperoxide synthase 2, and manganese
superoxide dismutase mRNAs in glial cells and macrophages
by inhibiting NF-kB and CCAAT/enhancer binding protein
beta pathways.38 Nontreated or controls cells exposed to
hypoxic conditions induced a 1.83-fold increase (P < .05) in
OGR1 expression compared with cells at normoxic condi-
tions (Figure 7C). TNF-treated cells in the presence of 0.05
Figure 5. (See previous page). Expression of pH-sensing receptors OGR1 and TDAG8 under hypoxic conditions was
inﬂuenced by pH in peritoneal macrophages from WT mice but not from Ogr1-/- mice. Mature quiescent peritoneal
macrophages from Ogr1-/- and WT mice were isolated and cultured at different pH values (7.7, 7.3, and 6.8) under normoxia or
hypoxia (0.2% O2) for 24 hours. mRNA isolation was performed and the expression of several genes was measured by RT-
qPCR. (A) OGR1 mRNA expression was signiﬁcantly higher in hypoxia at acidic pH. (B) TDAG8 mRNA expression was
signiﬁcantly higher in hypoxia at acidic pH values in WT cells. (C and D) The mRNA expression of proinﬂammatory cytokines,
IL6, and TNF was signiﬁcantly higher in hypoxia at pH 6.8, with an approximately 2-fold increase in WT cells. (E) At acidic pH
under hypoxia expression of SPARC was not increased. Results are expressed as means ± SEM (n ¼ 3). ***P < .001 using
1-way analysis of variance followed by the Tukey test.
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mmol/L AICAR showed a 41% decrease (1.2-fold decrease;
P < .001) compared with cells in the absence of the inhib-
itor (Figure 7C). The same treatment under hypoxic condi-
tions resulted in a comparable decrease (35% or 1.5-fold
decrease; P < .001). In the presence of SC-514 together with
TNF, OGR1 expression decreased 59% (1.7-fold decrease; P
< .001) compared with the relevant control without SC-514.
However, under hypoxic conditions the degree of inhibition
decreased signiﬁcantly (40% decrease equivalent to a
1.6-fold decrease; P < .001) (Figure 7C).
Transcriptional Regulation of OGR1 Under
Hypoxia Is Mediated by HIF-1a in THP1 Cells
After our results on the induction of OGR1 expression
under hypoxic conditions, we sought to elucidate the mo-
lecular mechanisms governing transcriptional regulation of
OGR1 under hypoxia. Sequence analysis of the OGR1 pro-
moter identiﬁed several putative binding sites for the
transcription factors NF-kB and HIF-1a. To investigate the
binding activity of HIF-1a and NF-kB to a promoter of OGR1,
we performed ChIP analysis of promoter regions containing
HIF-1a and NF-kB binding sites in THP1 cells after hypoxia
(0.2 % O2, 24 h) (Figure 8A). ChIP analysis showed that HIF-
1a, but not NF-kB, binds to the promoter of OGR1, 24 hours
after hypoxia in THP1 cells (Figure 8B).
Discussion
Tissue hypoxia stimulates multiple responses, including
glycolysis and the extrusion of lactic acid and protons,
thereby decreasing extracellular pH.39–41 One of the mecha-
nisms responsible for the high rate of glycolysis is HIF-1a, the
main hypoxic switch,42 which up-regulates the expression of
the glucose transporters GLUT1 and GLUT3,43 and the acti-
vation of the glycolytic enzymes lactate dehydrogenase,44
pyruvate dehydrogenase kinase-1,45 and pyruvate dehydro-
genase kinase-3.46 Tumor environment is characterized by
hypoxia and low pH, particularly at the core. Together with
GRP4, OGR1 and TDAG8 are major proton-sensing G-pro-
tein–coupled receptors that have been shown to play a role in
cancer, immune cell function, and inﬂammation.7,22,47,48 In
this study we showed that the mRNA expression of the pH
sensor OGR1 was increased 2-fold in murine tumor tissue.
Although small, the induction of OGR1 in tumor tissue is in
good agreement with the known interaction between tumor
hypoxia and acidosis,49 and several putative DNA binding
sites for HIF-1a within the proximal regions of the OGR1
promoter variants have been identiﬁed.22
In accordance with the severe hypoxic environment
and increased acidosis observed in the intestinal mucosa
in IBD,50,51we also show thatOGR1 expression is up-regulated
approximately 2-fold in CD and UC patients, however, 1 week
after hypoxia we observed a 4- and 6-fold increase in OGR1
expression in CD and UC patients, respectively, when
compared with healthy subjects. This result indicates that
OGR1 is an important regulatory factor contributing to the
onset of mucosal inﬂammation and a marker for IBD. Inter-
estingly, hypoxia caused by high altitude or airplane ﬂights has
been shown to trigger ﬂares of human IBD,52 which may be
mediated partially by changed expression of transporter
proteins and cytokine signaling.53 Interestingly, the constitu-
tive expression of TDAG8 was markedly higher in CD and UC
patients compared with healthy subjects. Conversely to OGR1,
the expression of TDAG8 was reduced signiﬁcantly in CD pa-
tients immediately and 1 week after hypoxia, and showed a
trend toward a reduced expression in UC patients subjected to
hypoxia. This down-regulation suggests a role for TDAG8 in
the negative regulation of proinﬂammatory responses, and
would be in agreement with several reports showing the
involvement of TDAG8 in the inhibition of immune re-
sponses.54,55 Interestingly, a recent report showed that
TDAG8 contributes to the inhibition of cytokine production
from extracellular acidiﬁcation in peritoneal macrophages.7
Taken together, these results point to a different function of
the 2 pH sensors OGR1 and TDAG8 in the regulation of in-
ﬂammatory responses. Reduction of TDAG8 expression under
hypoxia would reduce inhibitory effects on proinﬂammatory
gene expression, whereas increased OGR1 expression would
mediate proinﬂammatory responses directly.
We also show that OGR1 expression increases in human
monocytic cell lines, IECs, and macrophages subjected to
hypoxia, suggesting a pivotal role of OGR1 in hypoxia-
induced responses. In a previous study using OGR1-/-
mice, we showed that OGR1 plays a crucial role in the
expression of several main factors involved in immune re-
sponses and inﬂammation, including IL6, TNF, IL8, and
SPARC,22 a master regulator of tissue remodeling
and epithelial-mesenchymal transition (EMT).35,36 Accord-
ingly, the expression of IL6, TNF, IL8, and SPARC was
increased concomitantly with OGR1 under hypoxic and
acidic conditions. Interestingly, the expression of IL6 and
TNF was reduced signiﬁcantly in macrophages from OGR1-/-
mice, conﬁrming an essential role for OGR1 in hypoxia-
mediated inﬂammatory responses. Taken together, these
results suggest that OGR1 may play a crucial role in
inﬂammation and metabolic homeostasis under hypoxia and
acidic extracellular pH. In agreement with this, previous
studies have shown a critical role for OGR1 in proin-
ﬂammatory cytokine expression and tissue remodeling after
extracellular acidiﬁcation.56,57
Figure 6. (See previous page). Expression of pH-sensing receptors OGR1 and TDAG8 under hypoxic conditions was
inﬂuenced further by pH in human intestinal macrophages. Intestinal macrophages from healthy mucosa of carcinoma
patients were isolated and cultured at different pH values (7.7, 7.3, and 6.8) under normoxia or hypoxia (0.2% O2) for 24 hours.
mRNA isolation was performed and the expression of several genes was measured by RT-qPCR. (A) OGR1 mRNA expression
was signiﬁcantly higher in hypoxia at acidic pH. (B) TDAG8 mRNA expression was reduced in hypoxia in all pH levels tested.
(C–E) The mRNA expression of proinﬂammatory cytokines, IL6, IL8, and TNF was signiﬁcantly higher in hypoxia at pH 6.8. (F)
No differences in the mRNA expression of SPARC. Results are expressed as means ± SEM (n ¼ 5). *P < .05, **P < .01, and
***P < .001 using 1-way analysis of variance followed by the Tukey test.
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We show that hypoxia enhances TNF-mediated induction
of OGR1 expression. In a previous studywe reported that TNF
treatment induced OGR1 expression in MM6 cells and pri-
mary human and murine monocytes, and that this process
was reversed by the NF-kB inhibitors MG132, AICAR, BAY-11-
7082, CAY10512, and SC-514 in MM6 cells.22 In the current
study we show that hypoxia enhances TNF-mediated
induction of OGR1 expression, and that this effect was
reversed by NF-kB inhibition under hypoxic conditions. The 2
central transcription factors, HIF-1a and NF-kB, involved in
the regulation of decreased oxygen availability are known to
show an intimate interdependence at several mechanistic
levels.58 In a previous study we showed that an in silico
analysis using MatInspector software (Munich, Germany) and
Figure 7. Hypoxia enhances TNF induction of OGR1 expression and was reversed by NF-kB inhibitors in MM6 cells. TNF
treatment under hypoxia (0.2% O2). (A and B) After 6 hours, OGR1 mRNA expression was enhanced, but after 24 hours there
was a synergistic effect by hypoxia on TNF induction. The inhibitory effect of the NF-kB inhibitor SC-514 (25 mmol/L) was less
effective under hypoxia. (C) AICAR (0.05 mmol/L) showed less inhibitory effects under hypoxia. Each ﬁgure is representative of
3 independent experiments. Results are expressed as means ± SD. *P < .05, **P < .01, and ***P < .001 using 1-way analysis
of variance followed by the Tukey test.
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visual inspection showed several putative DNA binding sites
forNF-kB andHIF-1awithin the proximal regions of the OGR1
promoter variants.22 Accordingly, ChIP analysis of promoter
regions of OGR1 containing binding sites for HIF-1a and NF-
kB showed that hypoxia induced the binding of HIF-1a to the
OGR1 promoter in 2 different binding sites, -1680 and -668,
conﬁrming that OGR1 is under the transcriptional control of
HIF-1a. Of note, hypoxia did not induce the binding of NF-kB
to the -221, -959, and -1225 promoter binding sites, sug-
gesting an alternative mechanism for NF-kB to induce OGR1
expression that does not involve binding of NF-kB to this
promoter. Interestingly, a recent study using rabbits sub-
jected to hypoxia has shown that TNF induces the binding of
HIF-1a to the promoter of HIF-1a target genes through a NF-
kB–mediated mechanism that does not require the binding of
NF-kB to the promoter.59 This result could explain the in-
duction of OGR1 expression observed in TNF-treated cells
under hypoxia and the reversion of this effect with NF-kB
inhibitors. Furthermore, it has been shown that not only
hypoxic induction but also an increase in hydrogen ions re-
sults in transient and reversible loss of von Hippel-Lindau
function by promoting its nuclear sequestration,49 causing
activation of HIF-1a.
Conclusions
In this study we show that the hypoxic environment
triggers the expression of the pH-sensing receptor OGR1,
and this induction was enhanced at acidic pH, a common
feature of tumors and tissue inﬂammation, suggesting a role
for OGR1 in the physiological regulation associated with
hypoxia and tissue acidiﬁcation. We previously reported
that OGR1 expression was induced in cells of human
macrophage lineage and primary human monocytes by TNF
and that NF-kB inhibition reversed the induction of OGR1
mRNA expression by TNF. Here, we report that hypoxia,
known to cross-talk with the NF-kB pathway, enhanced the
TNF-mediated induction of OGR1 expression, which was
reversed in the presence of NF-kB inhibitors. The stimula-
tion of OGR1 expression by TNF and hypoxia, and
subsequent pH-sensing activity, may play a role in IBD
pathogenesis.
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